Skip to main page content (VSports最新版本)
U.S. flag

An official website of the United States government

Dot gov

The . gov means it’s official. Federal government websites often end in . gov or . mil VSports app下载. Before sharing sensitive information, make sure you’re on a federal government site. .

Https

The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely. V体育官网.

Review
. 2012 May 16;13(6):397-404.
doi: 10.1038/nrm3352.

Axis of ageing: telomeres, p53 and mitochondria

Ergün Sahin  1 , Ronald A DePinho
Affiliations
Review

"VSports在线直播" Axis of ageing: telomeres, p53 and mitochondria

"VSports app下载" Ergün Sahin et al. Nat Rev Mol Cell Biol. .

Abstract

Progressive DNA damage and mitochondrial decline are both considered to be prime instigators of natural ageing VSports手机版. Traditionally, these two pathways have been viewed largely in isolation. However, recent studies have revealed a molecular circuit that directly links DNA damage to compromised mitochondrial biogenesis and function via p53. This axis of ageing may account for both organ decline and disease development associated with advanced age and could illuminate a path for the development of relevant therapeutics. .

PubMed Disclaimer

Conflict of interest statement

Competing interests statement

The authors declare no competing financial interests.

Figures

Figure 1
Figure 1. Proposed causes of ageing
Major cellular pathways are implicated in the ageing process. Increased DNA damage, p53 and p16 activity and mitochondrial dysfunction have been shown to promote functional decline and ageing. By contrast, decreased activity in the mammalian target of rapamycin (mTOR), S6 kinase (S6K) and the insulin and insulin-like growth factor 1 (IGF1) pathways increase lifespan in different organisms.
Figure 2
Figure 2. Telomere–p53–PGC pathway
p53 induced by telomere dysfunction binds to the promoters of PPARγ co-activator 1α (PGC1α) and PGC1β and represses the expression of PGC1A and PGC1B. The repression of both co-activators impairs overall mitochondrial biogenesis and function and leads to defective ATP generation and increased levels of reactive oxygen species (ROS). PGCs are also involved in energy metabolism by regulating different biochemical pathways such as fatty acid oxidation, gluconeogenesis, glucose uptake and oxidation. The compromise in mitochondrial function and other biochemical pathways might equally lead to functional decline in tissue stem cells and post-mitotic tissues and drive ageing. Telomerase reactivation or PGC overexpression can reverse PGC-associated metabolic and mitochondrial changes in mice with established telomere dysfunction. Telomere dysfunction may also lead to compromised mitochondrial function and energy metabolism through other pathways (dashed arrows).
Figure 3
Figure 3. A unified theory of ageing
In this model, increased DNA damage (for example, owing to telomere attrition, impaired DNA repair and increased reactive oxygen species (ROS) levels) activates p53, and increasing levels of p53 ultimately lead to compromised mitochondrial function through the repression of PPARγ co-activator 1α (PGC1α) and PGC1β (which promote mitochondrial biogenesis). This p53-mediated mitochondrial dysfunction triggers a cycle of DNA damage (by affecting the production of ROS, iron–sulphur (Fe–S) clusters and NADH/NAD), which in turn leads to further p53 activation and mitochondrial compromise. This feed-forward loop could also account for the divergent and opposite effects of many players in the ageing process. Under mild stress conditions, several components depicted here (p53, mitochondria and AMP-activated protein kinase (AMPK)) have been shown to preserve cellular function but to promote cellular ageing under more severe stress conditions (see text). The interplay between p53 and other pathways that have been implicated in ageing is also indicated. p53 represses the activity of the insulin and insulin-like growth factor 1 (IGF1) pathway and the mammalian target of rapamycin (mTOR) pathway and activates AMPK. How the altered activity of these pathways modifies mitochondrial function and the ageing process in the setting of increased DNA damage is not clear. Other p53-dependent and p53-independent pathways might cooperate in inducing mitochondrial dysfunction. For example, BMI1 indirectly inhibits p53 activation, and BMI1 loss upregulates p16 expression, which increases p53 activity indirectly (dashed arrow) by interacting with MDM2, the negative regulator of p53 (not shown). BMI1 has also been shown to induce mitochondrial dysfunction (probably indirectly). In addition, loss of sirtuins may contribute to mitochondrial dysfunction, as active sirtuin 1 (SIRT1) decreases p53 activity, and loss of SIRT1 promotes p53 activation and its downstream functions. SIRT1 also activates PGC1α and thereby boosts mitochondrial biogenesis. The consequences of mitochondrial dysfunction are, when mild, functional impairment (for example, decreased ATP generation and β-oxidation) without cell loss. However, under increased stress conditions, mitochondrial dysfunction leads to functional impairment and concomitant loss of parenchymal mass owing to increased apoptosis and senescence.
See this image and copyright information in PMC

References

    1. Christensen K, Doblhammer G, Rau R, Vaupel JW. Ageing populations: the challenges ahead. Lancet. 2009;374:1196–1208. - PMC - PubMed
    1. Kenyon C, Chang J, Gensch E, Rudner A, Tabtiang RA. C. elegans mutant that lives twice as long as wild type. Nature. 1993;366:461–464. - "VSports" PubMed
    1. Kenyon CJ. The genetics of ageing. Nature. 2010;464:504–512. - PubMed
    1. Deelen J, et al. Gene set analysis of GWAS data for human longevity highlights the relevance of the insulin/IGF-1 signaling and telomere maintenance pathways. Age (Dordr) 2011 Nov 24; doi: 10.1007/s11357-011-9340-3. - DOI - PMC - PubMed
    1. Ziv E, Hu D. Genetic variation in insulin/IGF-1 signaling pathways and longevity. Ageing Res Rev. 2011;10:201–204. - PubMed

"V体育2025版" Publication types

V体育平台登录 - MeSH terms

Substances (VSports手机版)